Ghent University Academic Bibliography

Your filters: cql: author exact 00B083B8-F0EE-11E1-A9DE-61C894A0A6B4

Add to list
Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphne Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2026) CLINICAL MICROBIOLOGY AND INFECTION. 32(2). p.266-271
Add to list
- Journal Article
- open access
Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trial.

Pieter De Cock (UGent) , Roos Colman (UGent) , Anne Smits, Fiammetta Piersigilli, Marleen Renard, An Van Damme, Alexander Clarysse, Evelyn Dhont (UGent) , Sophie Vanhaesebrouck (UGent) , Victoria Bordon, et al.

(2026) The Lancet. Child & adolescent health. p.S2352-4642(25)00385
Add to list
- Conference Paper
- C3
Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphné Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2025) European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP), 21st Congress, Abstracts. In Pediatric Drugs 27(4). p.518-519
Add to list
- Journal Article
- A1
- open access
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections : a real world prospective study

Anne-Sophie Messiaen (UGent) , Stien Vandendriessche (UGent) , Emilie De Muynck, Gregory Strubbe (UGent) , Liesbet De Bus (UGent) , Petra Schelstraete (UGent) , Kristen Decommer, Sanne De Smet (UGent) , Alexander Soetens, Leslie Naesens (UGent) , et al.

(2025) EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 44(4). p.847-853
Add to list
Shifts in systemic inflammatory profiles on elexacaftor/tezacaftor/ivacaftor predict clinical outcomes in cystic fibrosis

Leander Jonckheere (UGent) , Lieve Vande Sande, Iris Janssens (UGent) , Yannick Vande Weygaerde (UGent) , Stephanie Van Biervliet (UGent) , Heidi Schaballie (UGent) , Petra Schelstraete (UGent) , Tania Maes (UGent) , Cedric Bosteels (UGent) and Eva Van Braeckel (UGent)

(2025) JOURNAL OF CYSTIC FIBROSIS. In Journal of Cystic Fibrosis 24(Supplement 1). p.S20-S20

Academic Bibliography

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trial.

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Impact of reporting rapid susceptibility results in Gram negative bloodstream infections : a real world prospective study

Shifts in systemic inflammatory profiles on elexacaftor/tezacaftor/ivacaftor predict clinical outcomes in cystic fibrosis

Contents

Support

Contact